logo icmab ochoa 02 01 logo icmab ochoa 02 01
  • NEWS

Anna Roig, 2017 Albus Grifols Award for an albumin-related research project

Anna Roig has been awarded with the Albus Award 2017, one of the Scientific Awards offered by Grifols, the pharmaceutical and chemical multinational company. The Award consists of 50,000 € to carry out the project "Albumin-iron oxide nanocages"

The Albus Program is an annual international award focused on innovative ideas related to albumin and its role as a therapeutic product. Proposals should seek to develop novel concepts on albumin research, encourage discovery of beneficial albumin applications and further investigate mechanisms of action or clinical effects in different indications.

Albumin is a globular protein, the most common one being serum albumin, which is the main protein of human blood plasma. The proposals for the Albus Program may include, but are not limited to, research related to this protein: efficacy, mechanism of action, safety and tolerability, quality of life and pharmacoeconomics. 

The Program offers two awards of 50,000 € each year. The proposals are assessed by an independent review committee formed by world-wide recognized experts

Anna's "Albumin-iron oxide nanocages" project gets inspiration from the apoferritin nanoconstructs. It aims to investigate if albumin nanocages, consisting of a few units of albumin self-assembled and self-standing, can be formed by using inorganic iron oxide nanoparticles as semi-sacrificial templates. The albumin nanocages could then find application as a nanomedicinal product for imaging and drug delivery.

The winners will be given their Awards at the Ceremony that will take place on October 3rd, 2017 in Barcelona.

About Grifols Scientic Awards: Grifols' commitment to the research community is embodied in Grifols Scientific Awards. Over the years, Grifols has established various awards that promote and recognize research in areas related to their core business of plasma-derived proteins: albumin, alpha-1 antitrypsin, hemostasis, antithrombin and immunoglobulin. 


See more posts on ICMAB related to: Anna Roig , Albus Award

Also on ICMAB...

  • Iron oxide nanoparticles stress the cells

    07 August 2017 872 hit(s)

    ICMAB researchers lead a study on the toxicity of iron oxide nanoparticles based on the analysis of specific genetic markers linked to nanotoxicity in the C. elegans organisms. Part of the experiment, published in the journal Nanotoxicology, has been carried out at the ALBA Synchrotron, in its infrared light MIRAS beamline. The study suggests that nanoparticles can be captured by intestinal cells in their interior, they can interact with cell lipids, and they can activate cellular mechanisms of oxidative stress.
  • Three INPhINIT "la Caixa" Research Fellows will start their PhD at ICMAB on September 2017

    03 August 2017 862 hit(s)

    We are very happy to announce that, out of a total of 57 PhD positions offered by the INPhINIT doctoral fellowship for outstanding early-stage researchers, the Institute of Materials Science of Barcelona (ICMAB) will welcome three new PhD students, placing the Institute fourth among the 28 centres that were chosen.